Cytokine modulation of atopic dermatitis filaggrin skin expression
Michael Howell(University of California San Diego), Donald Y.M. Leung(Boston Children's Hospital), Kathleen C. Barnes(Johns Hopkins University), Audrey V. Grant(Johns Hopkins University), Anna DeBenedetto(University of Rochester Medicine), Mark Boguniewicz(University of Colorado Denver), Lynda C. Schneider(Boston Children's Hospital), Byung Eui Kim(National Jewish Health), Lisa A. Beck(University of Rochester Medicine), Peisong Gao(Johns Hopkins University)
Cited by 464
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k
Cytokine modulation of atopic dermatitis filaggrin skin expression
|Journal of Allergy and Clinical Immunology|2007|1.1k